Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3601 - 3625 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Diacylglycerophosphoinositolglycans LMGP15010223
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(18:2(9Z,12Z)/18:1(9Z))
126457591 1670.805608 C75H131O38P
Gangliosides LMSP0601BD01
  • Fuc-GM1(d18:1/16:0)
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262196 1663.903272 C77H137N3O35
Gangliosides LMSP0601CH01
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Sialyl-Lea(d18:1/16:0)
44262428 1663.903272 C77H137N3O35
Gangliosides LMSP0601DL01
  • NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialyl-Lea(d18:1/16:0)
44262636 1663.903272 C77H137N3O35
Gangliosides LMSP0601DS01
  • Galbeta1-3(NeuAcalpha2-6)(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262692 1663.903272 C77H137N3O35
Gangliosides LMSP0601EE01
  • NeuAcalpha2-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • sialyl-Lex(d18:1/16:0)
44262780 1663.903272 C77H137N3O35
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ05
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260296 1662.980793 C80H146N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44260416 1662.980793 C80H146N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA05
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44261632 1662.980793 C80H146N2O33
Diacylglycerophosphoinositolglycans LMGP15010204
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/18:0)
126457572 1662.836908 C74H135O38P
Diacylglycerophosphoinositolglycans LMGP15010225
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/16:0)
126457593 1662.836908 C74H135O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ07
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260298 1660.965143 C80H144N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF07
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44260418 1660.965143 C80H144N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA07
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44261634 1660.965143 C80H144N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BB02
  • GalNAcalpha1-3GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260381 1660.939991 C78H140N4O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AL02
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261901 1660.939991 C78H140N4O33
Diacylglycerophosphoinositolglycans LMGP15010205
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(17:0/18:1(9Z))
126457573 1660.821258 C74H133O38P
Diacylglycerophosphoinositolglycans LMGP15010226
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:0/16:1(9Z))
126457594 1660.821258 C74H133O38P
Diacylglycerophosphoinositolglycans LMGP15010231
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM5(19:1(9Z)/16:0)
126457599 1660.821258 C74H133O38P
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BH04
  • Fucalpha2-3GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260431 1659.981127 C80H145N3O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AG04
  • Fucalpha1-3GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260535 1659.981127 C80H145N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AF04
  • GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type I A antigen(d18:1/22:0)
44260655 1659.981127 C80H145N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AK04
  • Fucalpha1-4GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260695 1659.981127 C80H145N3O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AR04
  • GlcNAcbeta1-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260751 1659.981127 C80H145N3O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AF04
  • GalNAcbeta1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • type II A antigen(d18:1/22:0)
44261015 1659.981127 C80H145N3O32

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024